Drugs that contain Ranolazine

1. Drug name - ASPRUZYO SPRINKLE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10898444 SPIL Extended release multiparticulates of ranolazine
Jan, 2038

(15 years from now)

Market Authorisation Date: 28 February, 2022

Treatment: NA

Dosage: GRANULES, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
1GM GRANULES, EXTENDED RELEASE;ORAL Prescription
500MG GRANULES, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in